Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
VaccinesVeterinary Medicine

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1402926

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1402926

Livestock Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

PUBLISHED:
PAGES: 165 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

Description

Table of Contents

List of Tables

Livestock Vaccines Market - Scope of Report

TMR's report on the global livestock vaccines market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global livestock vaccines market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global livestock vaccines market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the livestock vaccines market.

Market Snapshot
Market Value in 2023US$ 5.4 Bn
Market Value in 2031US$ 9.4 Bn
CAGR6.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global livestock vaccines market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global livestock vaccines market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global livestock vaccines market.

The report delves into the competitive landscape of the global livestock vaccines market. Key players operating in the global livestock vaccines market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global livestock vaccines market profiled in this report.

Key Questions Answered in Global livestock vaccines Market Report:

  • What is the sales/revenue generated by livestock vaccines across all regions during the forecast period?
  • What are the opportunities in the global livestock vaccines market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Livestock Vaccines Market - Research Objectives and Research Approach

The comprehensive report on the global livestock vaccines market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global livestock vaccines market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global livestock vaccines market.

Show more
Product Code: TMRGL85857

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Livestock Vaccines Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Livestock Vaccines Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Disease Epidemiology
  • 5.2. Pipeline Analysis
  • 5.3. Key Industry Events
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Livestock Vaccines Market Analysis and Forecast, by Vaccine Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Vaccine Type, 2023-2031
    • 6.3.1. Bovine Vaccine
    • 6.3.2. Poultry Vaccine
    • 6.3.3. Porcine Vaccine
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Vaccine Type

7. Global Livestock Vaccines Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2023-2031
    • 7.3.1. Live Attenuated Vaccine
    • 7.3.2. Inactivated Vaccine
    • 7.3.3. Recombinant Vaccine
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global Livestock Vaccines Market Analysis and Forecasts, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Livestock Vaccines Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2023-2031
    • 9.3.1. Veterinary Hospitals
    • 9.3.2. Veterinary Clinics
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Livestock Vaccines Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2023-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Livestock Vaccines Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 11.2.1. Bovine Vaccine
    • 11.2.2. Poultry Vaccine
    • 11.2.3. Poultry Vaccine
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Technology, 2023-2031
    • 11.3.1. Live Attenuated Vaccine
    • 11.3.2. Inactivated Vaccine
    • 11.3.3. Recombinant Vaccine
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 11.4.1. Oral
    • 11.4.2. Parenteral
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2023-2031
    • 11.5.1. Veterinary Hospitals
    • 11.5.2. Veterinary Clinics
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2023-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Vaccine Type
    • 11.7.2. By Technology
    • 11.7.3. By Route of Administration
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe Livestock Vaccines Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 12.2.1. Bovine Vaccine
    • 12.2.2. Poultry Vaccine
    • 12.2.3. Porcine Vaccine
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Technology, 2023-2031
    • 12.3.1. Live Attenuated Vaccine
    • 12.3.2. Inactivated Vaccine
    • 12.3.3. Recombinant Vaccine
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 12.4.1. Oral
    • 12.4.2. Parenteral
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2023-2031
    • 12.5.1. Veterinary Hospitals
    • 12.5.2. Veterinary Clinics
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Vaccine Type
    • 12.7.2. By Technology
    • 12.7.3. By Route of Administration
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Livestock Vaccines Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 13.2.1. Bovine Vaccine
    • 13.2.2. Poultry Vaccine
    • 13.2.3. Porcine Vaccine
    • 13.2.4. others
  • 13.3. Market Value Forecast, by Technology, 2023-2031
    • 13.3.1. Live Attenuated Vaccine
    • 13.3.2. Inactivated Vaccine
    • 13.3.3. Recombinant Vaccine
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 13.4.1. Oral
    • 13.4.2. Parenteral
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2023-2031
    • 13.5.1. Veterinary Hospitals
    • 13.5.2. Veterinary Clinics
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Vaccine Type
    • 13.7.2. By Technology
    • 13.7.3. By Route of Administration
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Livestock Vaccines Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 14.2.1. Bovine Vaccine
    • 14.2.2. Poultry Vaccine
    • 14.2.3. Porcine Vaccine
    • 14.2.4. Others Vaccine
  • 14.3. Market Value Forecast, by Technology, 2023-2031
    • 14.3.1. Live Attenuated Vaccine
    • 14.3.2. Inactivated Vaccine
    • 14.3.3. Recombinant Vaccine
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 14.4.1. Oral
    • 14.4.2. Parenteral
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2023-2031
    • 14.5.1. Veterinary Hospitals
    • 14.5.2. Veterinary Clinics
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Vaccine Type
    • 14.7.2. By Technology
    • 14.7.3. By Route of Administration
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Livestock Vaccines Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 15.2.1. Bovine Vaccine
    • 15.2.2. Poultry Vaccine
    • 15.2.3. Porcine Vaccine
    • 15.2.4. Others
  • 15.3. Market Value Forecast, by Technology, 2023-2031
    • 15.3.1. Live Attenuated Vaccine
    • 15.3.2. Inactivated Vaccine
    • 15.3.3. Recombinant Vaccine
    • 15.3.4. Others
  • 15.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 15.4.1. Oral
    • 15.4.2. Parenteral
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2023-2031
    • 15.5.1. Veterinary Hospitals
    • 15.5.2. Veterinary Clinics
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Vaccine Type
    • 15.7.2. By Technology
    • 15.7.3. By Route of Administration
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Dechra Pharmaceuticals PLC
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Ceva Sante Animale
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Elanco
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck & Co., Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Zoetis Services LLC
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Boehringer Ingelheim International GmbH.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Virbac
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Biogenesis Bago
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Ourofino Saude Animal
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. VETAL Animal Health Products, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Other prominent Players
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
Show more
Product Code: TMRGL85857

List of Tables

  • Table 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 02: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 03: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 04: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 05: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 06: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 07: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 08: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 09: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 10: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 11: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 12: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 13: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 14: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 15: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 16: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 17: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 18: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 19: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 20: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 21: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 23: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 24: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 25: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 26: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 27: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 28: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 29: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 30: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031

List of Figures

  • Figure 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 02: Global Livestock Vaccines Market Value Share, by Vaccine Type, 2022
  • Figure 03: Livestock Vaccines Market Value Share, by Technology, 2022
  • Figure 04: Livestock Vaccines Market Value Share, by Route of Administration, 2022
  • Figure 05: Global Livestock Vaccines Market Value Share, by End-user, 2022
  • Figure 06: Global Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 07: Global Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 08: Global Livestock Vaccines Market Revenue (US$ Mn), by Bovine Vaccine , 2023-2031
  • Figure 09: Global Livestock Vaccines Market Revenue (US$ Mn), by Poultry Vaccine, 2023-2031
  • Figure 10: Global Livestock Vaccines Market Revenue (US$ Mn), by Porcine Vaccine, 2023-2031
  • Figure 11: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 12: Global Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 13: Global Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 14: Global Livestock Vaccines Market Value (US$ Mn), by Live Attenuated Vaccine, 2023-2031
  • Figure 15: Global Livestock Vaccines Market Value (US$ Mn), by Inactivated Vaccine, 2023-2031
  • Figure 16: Global Livestock Vaccines Market Value (US$ Mn), by Recombinant Vaccine, 2023-2031
  • Figure 17: Global Livestock Vaccines Market Value (US$ Mn), by Others, 2023-2031
  • Figure 18: Global Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 19: Global Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 20: Global Livestock Vaccines Market Revenue (US$ Mn), by Oral , 2023-2031
  • Figure 21: Global Livestock Vaccines Market Revenue (US$ Mn), by Parenteral, 2023-2031
  • Figure 22: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 23: Global Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: Global Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 25: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Hospitals, 2023-2031
  • Figure 26: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Clinics, 2023-2031
  • Figure 27: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 28: Global Livestock Vaccines Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 29: Global Livestock Vaccines Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 30: North America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 31: North America Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 32: North America Livestock Vaccines Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 33: North America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 34: North America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 35: North America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 36: North America Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 37: North America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 38: North America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 39: North America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: North America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 42: Europe Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 43: Europe Livestock Vaccines Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 44: Europe Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 45: Europe Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 46: Europe Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 47: Europe Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 48: Europe Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 49: Europe Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 50: Europe Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Europe Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 53: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 56: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 57: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 58: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 59: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 60: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 61: Asia Pacific Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 63: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 64: Latin America Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 65: Latin America Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 66: Latin America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 67: Latin America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 68: Latin America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 69: Latin America Livestock Vaccines Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 70: Latin America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 71: Latin America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 72: Latin America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 74: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 75: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 76: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 77: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 78: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 79: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 80: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 81: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 82: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 83: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 84: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 85: Global Livestock Vaccines Market Share Analysis By Company (2022)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!